Speaking at the India Mobile Congress, he said mobile technology has enabled benefits worth billions of dollars to reach the deserving and also helped the poor and vulnerable during the pandemic. “It is also with the help of mobile technology that we will embark on one of the world’s largest COVID-19 vaccination drive,” he said.
While Pfizer India has applied to drug regulator for permission to import its experimental mRNA vaccine for sale and distribution without the requirement for local clinical trials, Serum Institute of India Ltd, AstraZeneca’s India vaccine partner, has applied for emergency use authorisation using data from Phase-III trials that were conducted locally, as well as in Brazil and the UK.
Hyderabad-based Bharat Biotech has sought nod Covaxin which is being indigenously developed in collaboration with the Indian Council of Medical Research (ICMR).
The applications mean that a mass vaccine effort could be shortly underway in a nation that has the world’s second-largest coronavirus caseload.
Also in Explained | India’s road to mass vaccination against Covid-19
At the IMC, Modi said, “We need to work together to ensure a timely roll-out of 5G to leapfrog into the future and empower millions of Indians.” He also pitched for making India a global hub for telecom equipment, design, development and manufacturing.
(With inputs from PTI)